Larvol Delta - Earlier-this-month-Agios-announced-that-the-US-Food-and-Drug-Administration-FDA-accepted-its-supplemental-New-Drug-Application-sNDA-for-the-accelerated-approval-of-mitapivat-an-oral-PK-activator-in-sickle-cell-disease-with-a-Priority-Review

tebapivat (AG-946) - Agios Pharmaceuticals

https://investor.agios.com/news-releases/news-release-details/agios-provides-update-phase-2-trial-tebapivat-sickle-cell

Jul 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next